Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for alcohol withdrawal
Plenary Presentations
DECREASING ADMISSIONS, READMISSIONS AND LENGTH OF STAY WHILE IMPROVING PATIENT SAFETY FOR ALCOHOL WITHDRAWAL SYNDROME
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There were nearly 33,000 admissions to Department of Veterans Affairs hospitals for alcohol withdrawal syndrome (AWS) in fiscal year 2017. Symptom-triggered management is the standard of care and, when employed effectively, the number of medication doses during admission is a good proxy for clinical severity of withdrawal. Several evidence-based algorithms for outpatient management of [...]
Oral Presentations
Abstract Number: 15
IMPROVED ALCOHOL USE DISORDER TREATMENT LEADING TO DECREASED READMISSION RATES
SHM Converge 2024
Background: Affecting approximately 5.9% of the US population, alcohol use disorder (AUD) has been established as a prevalent disease in this country (1). Through repeated hospital admissions for alcohol use disorder (including alcohol withdrawal syndromes), hospital costs have steadily risen to recent estimates of 7.6 billion dollars in 2017 (2). Without the establishment of outpatient [...]
Plenary Presentations
DECREASING ADMISSIONS, READMISSIONS AND LENGTH OF STAY WHILE IMPROVING PATIENT SAFETY FOR ALCOHOL WITHDRAWAL SYNDROME
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There were nearly 33,000 admissions to Department of Veterans Affairs hospitals for alcohol withdrawal syndrome (AWS) in fiscal year 2017. Symptom-triggered management is the standard of care and, when employed effectively, the number of medication doses during admission is a good proxy for clinical severity of withdrawal. Several evidence-based algorithms for outpatient management of [...]
Oral Presentations
Abstract Number: 15
IMPROVED ALCOHOL USE DISORDER TREATMENT LEADING TO DECREASED READMISSION RATES
SHM Converge 2024
Background: Affecting approximately 5.9% of the US population, alcohol use disorder (AUD) has been established as a prevalent disease in this country (1). Through repeated hospital admissions for alcohol use disorder (including alcohol withdrawal syndromes), hospital costs have steadily risen to recent estimates of 7.6 billion dollars in 2017 (2). Without the establishment of outpatient [...]
Abstract Number: 20
AN INNOVATIVE ALCOHOL WITHDRAWAL PROTOCOL REDUCES LENGTH OF STAY, RESTRAINT USE, AND TRANSFERS TO INTENSIVE CARE
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Alcohol withdrawal is a common disorder faced by hospitalists. The pharmacologic standard of care involves the use of benzodiazepines, administered either as fixed doses or with doses adjusted per patient symptoms. At our institution, the alcohol withdrawal protocol previously in place used an institution-specific scale to evaluate patient symptoms, and nurses had latitude within [...]
Abstract Number: 44
PHENOBARBITAL VS. SYMPTOM TRIGGERED LORAZEPAM FOR ALCOHOL WITHDRAWAL ON GENMED
SHM Converge 2023
Background: Alcohol withdrawal is a common issue in hospitalized patients and is associated with significant morbidity and mortality. Alcohol withdrawal occurs when the gamma aminobutyric acid (GABA) stimulating effect of alcohol is removed, resulting in an excess of the excitatory neurotransmitter glutamate. Treatment typically consists of as needed benzodiazepines, which activate GABA. However, this reactive [...]
Abstract Number: 138
A COMPARISON OF BAWS (BRIEF ALCOHOL WITHDRAWAL SCALE) WITH CIWA-AR TO DIAGNOSE THE SEVERITY OF ALCOHOL WITHDRAWAL IN HOSPITALIZED MEDICAL PATIENTS
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Treating alcohol withdrawal in the inpatient medical setting requires timely identification of the severity of alcohol withdrawal so appropriate treatment can be administered. Delayed or missed diagnosis can lead to increased morbidity and mortality, increased cost and length of stay, and ICU admissions. CIWA-Ar is the most commonly used scale, but it is lengthy [...]
Abstract Number: 145
COMPARISON OF PHENOBARBITAL AND LORAZEPAM PROTOCOLS FOR INPATIENT ALCOHOL WITHDRAWAL SYNDROME; A RETROSPECTIVE COHORT STUDY
SHM Converge 2024
Background: Alcohol use disorder (AUD) Is present in 10% of adults and its prevalence is increasing. When patients with AUD are admitted to the hospital, half develop alcohol withdrawal syndrome (AWS), which can cause delirium, hallucinations, seizures, and even mortality if not treated appropriately. A fixed-dose phenobarbital strategy may be superior to the standard of [...]
Abstract Number: 156
CLINICAL CHARACTERISTICS AND OUTCOMES OF VETERANS HOSPITALIZED WITH ALCOHOL WITHDRAWAL
SHM Converge 2023
Background: Although alcohol withdrawal (AW) is common in hospitalized patients, few studies describe contemporary alcohol withdrawal management in hospitalized settings or compare practices to recent guidelines published by the American Society of Addiction Medicine (ASAM). We sought to describe patient characteristics and determine factors associated with complicated withdrawal and treatment duration in hospitalized patients with [...]
Abstract Number: 173
OUTCOMES OF STANDARDIZED MINNESOTA DETOXIFICATION SCALE (MINDS) ASSESSMENT WITH HIGH DOSE DIAZEPAM TREATMENT FOR ALCOHOL WITHDRAWAL IN HOSPITALIZED PATIENTS
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Approximately 1.6 million men and 800,000 women in the US are alcohol dependent and have an alcohol-use disorder. Half will experience withdrawal symptoms after decreased alcohol consumption. Complications including seizures and delirium tremens occur in 3-5% . Benzodiazepines are the gold standard for treatment of alcohol withdrawal but choice of drug regimens varies widely. [...]
1 2 Next ›
  • This Week

  • This Month

  • All Time

  • This Week

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • ADDERALL INDUCED ISCHEMIC COLITIS

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE

  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations

  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN

© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top